Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of ARS 273.12 trillion. The enterprise value is 307.99 trillion.
Market Cap | 273.12T |
Enterprise Value | 307.99T |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.77% |
Shares Change (QoQ) | -0.71% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.49B |
Valuation Ratios
The trailing PE ratio is 13.97 and the forward PE ratio is 9.15.
PE Ratio | 13.97 |
Forward PE | 9.15 |
PS Ratio | 3.60 |
PB Ratio | 4.67 |
P/TBV Ratio | 18.77 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.27, with an EV/FCF ratio of 17.55.
EV / Earnings | 15.75 |
EV / Sales | 3.73 |
EV / EBITDA | 8.27 |
EV / EBIT | 9.90 |
EV / FCF | 17.55 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.
Current Ratio | 1.42 |
Quick Ratio | 0.82 |
Debt / Equity | 0.72 |
Debt / EBITDA | 1.23 |
Debt / FCF | 2.40 |
Interest Coverage | 18.77 |
Financial Efficiency
Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.04%.
Return on Equity (ROE) | 35.42% |
Return on Assets (ROA) | 13.01% |
Return on Invested Capital (ROIC) | 18.04% |
Return on Capital Employed (ROCE) | 26.18% |
Revenue Per Employee | 1.02B |
Profits Per Employee | 264.20M |
Employee Count | 75,000 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.20 |
Taxes
In the past 12 months, Merck & Co. has paid 3.27 trillion in taxes.
Income Tax | 3.27T |
Effective Tax Rate | 14.32% |
Stock Price Statistics
The stock price has decreased by -25.26% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.
Beta (5Y) | 0.39 |
52-Week Price Change | -25.26% |
50-Day Moving Average | 20,386.50 |
200-Day Moving Average | 21,538.50 |
Relative Strength Index (RSI) | 57.98 |
Average Volume (20 Days) | 6,803 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, Merck & Co. had revenue of ARS 75.81 trillion and earned 19.55 trillion in profits. Earnings per share was 7,728.34.
Revenue | 75.81T |
Gross Profit | 58.69T |
Operating Income | 28.54T |
Pretax Income | 22.84T |
Net Income | 19.55T |
EBITDA | 33.76T |
EBIT | 28.54T |
Earnings Per Share (EPS) | 7,728.34 |
Balance Sheet
The company has 10.27 trillion in cash and 42.19 trillion in debt, giving a net cash position of -31,913.73 billion.
Cash & Cash Equivalents | 10.27T |
Total Debt | 42.19T |
Net Cash | -31,913.73B |
Net Cash Per Share | n/a |
Equity (Book Value) | 58.46T |
Book Value Per Share | 23,324.68 |
Working Capital | 13.14T |
Cash Flow
In the last 12 months, operating cash flow was 22.09 trillion and capital expenditures -4,542.76 billion, giving a free cash flow of 17.54 trillion.
Operating Cash Flow | 22.09T |
Capital Expenditures | -4,542.76B |
Free Cash Flow | 17.54T |
FCF Per Share | n/a |
Margins
Gross margin is 77.41%, with operating and profit margins of 37.64% and 25.79%.
Gross Margin | 77.41% |
Operating Margin | 37.64% |
Pretax Margin | 30.12% |
Profit Margin | 25.79% |
EBITDA Margin | 44.53% |
EBIT Margin | 37.64% |
FCF Margin | 23.14% |
Dividends & Yields
This stock pays an annual dividend of 435.90, which amounts to a dividend yield of 2.00%.
Dividend Per Share | 435.90 |
Dividend Yield | 2.00% |
Dividend Growth (YoY) | 53.18% |
Years of Dividend Growth | 2 |
Payout Ratio | 48.95% |
Buyback Yield | 0.77% |
Shareholder Yield | 2.77% |
Earnings Yield | 7.16% |
FCF Yield | 6.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 4.33 and a Piotroski F-Score of 6.
Altman Z-Score | 4.33 |
Piotroski F-Score | 6 |